loco
The intrinsic GTPase activity of transducin (the Galpha subunit involved in visual transduction) controls inactivation of the effector enzyme, cGMP
phosphodiesterase (PDE), during turnoff of the visual signal. The inhibitory gamma-subunit of PDE
(Pgamma), an unidentified membrane factor and a retinal specific member of the RGS family of proteins
have been shown to accelerate GTP hydrolysis by transducin. A human homolog of
murine retinal specific RGS (hRGSr) was expressed in Escherichia coli and its role in the regulation of
transducin GTPase activity was investigated. As with other RGS proteins, hRGSr interacts preferentially with a transitional
conformation of the transducin alpha-subunit, while its binding to
GtalphaGTPgammaS or GtalphaGDP is weak. hRGSr and Pgamma do not compete for the interaction
with the transducin alpha-subunit. The affinity of the Pgamma interaction with transducin alpha-subunit is modestly enhanced
by the addition of hRGSr. In a single
turnover assay, hRGSr accelerates the GTPase activity of transducin reconstituted with the urea-stripped rod
outer segment (ROS) membranes by more than 10-fold. Addition of Pgamma to the
reconstituted system reduces the GTPase level accelerated by hRGSr. The GTPase
activity of transducin and the PDE inactivation rates in native ROS membranes in the presence of hRGSr
are elevated 3-fold or more regardless of the membrane concentrations. In ROS suspensions containing
30 microM rhodopsin these rates are elevated even further. These data suggest that the effects of hRGSr on
transducin's GTPase activity are attenuated by Pgamma but independent of a putative membrane GTPase
activating protein factor. The rate of transducin GTPase activity in the presence of hRGSr is sufficient to
correlate it with in vivo turnoff kinetics of the visual cascade (Natochin, 1997).
The rod outer segment phototransduction GAP (GTPase-accelerating protein) has been identified as
RGS9, a member of the RGS family of G alpha GAPs. RGS9 mRNA expression is specific for
photoreceptor cells, and RGS9 protein colocalizes with other phototransduction components to
photoreceptor outer segment membranes. The RGS domain of RGS9 accelerates GTP hydrolysis by the
visual G protein transducin, and this acceleration is enhanced by the gamma subunit of the
phototransduction effector cGMP phosphodiesterase. These unique properties of RGS9
match those of the rod outer segment GAP and implicate it as a key element in the recovery phase of
visual transduction (He, 1998).
Proteins of the regulators of G protein signaling (RGS) family modulate the duration of intracellular
signaling by stimulating the GTPase activity of G protein alpha subunits. It has been established that the
ninth member of the RGS family (RGS9) participates in accelerating the GTPase activity of the
photoreceptor-specific G protein, transducin. This process is essential for timely inactivation of the
phototransduction cascade during the recovery from a photoresponse. Functionally
active RGS9 from vertebrate photoreceptors exists as a tight complex with the long splice variant of the
G protein beta subunit (Gbeta5L). RGS9 and Gbeta5L also form a complex when coexpressed in cell
culture. These data are consistent with the recent observation that several RGS proteins, including RGS9,
contain a G protein gamma-subunit like domain that can mediate RGS protein association with Gbeta5. An example
of such a complex is reported whose cellular localization and function are clearly defined (Makino, 1999).
RGS proteins (regulators of G protein signaling) are potent accelerators of the intrinsic GTPase activity of
G protein alpha subunits (GAPs), thus controlling the response kinetics of a variety of cell signaling
processes. Most RGS domains that have been studied have relatively little GTPase activating specificity
especially for G proteins within the Gi subfamily. Retinal RGS9 is unique in its ability to act synergistically
with a downstream effector cGMP phosphodiesterase to stimulate the GTPase activity of the alpha
subunit of transducin, Galphat. Another unique property of RGS9 is reported: high specificity for
Galphat. The core (RGS) domain of RGS9 stimulates Galphat GTPase activity 10-fold and
Galphai1 GTPase activity only 2-fold at a concentration of 10 muM. Using chimeric Galphat/Galphai1
subunits it has been demonstrated that the alpha-helical domain of Galphat imparts this specificity. The functional
effects of RGS9 are well correlated with its affinity for activated Galpha subunits as measured by a
change in fluorescence of a mutant Galphat (Chi6b) selectively labeled at Cys-210. Kd values for RGS9
complexes with Galphat and Galphai1 calculated from the direct binding and competition experiments
are 185 nM and 2 muM, respectively. The gamma subunit of phosphodiesterase increases the GAP
activity of RGS9. This is because of the ability of Pgamma to increase the affinity of
RGS9 for Galphat. A distinct, nonoverlapping pattern of RGS and Pgamma interaction with Galphat
suggests a unique mechanism of effector-mediated GAP function of the RGS9 (Skiba, 1999).
Serpentine Galphai-linked receptors support rapid adhesion and directed migration of leukocytes and other
cell types. The intracellular mechanisms mediating and regulating chemoattractant-directed adhesion and
locomotion are only now beginning to be explored. Little is known about the GTPase activity of the Galphai proteins involved in adhesion and
chemotaxis, or the significance of their regulation to these responses. Using transiently transfected
lymphoid cells as a model system, it has been shown that expression of RGS1, RGS3, and RGS4 inhibits
chemoattractant-induced migration. In contrast, RGS2, a regulator of Galphaq activity, has no effect on
cell migration to any chemoattractant. RGS1, RGS3, and RGS4 also reduce rapid
chemoattractant-triggered adhesion, although the proadhesive response appears quantitatively less
sensitive to RGS action than chemotaxis. The results suggest that the duration of the Galphai signal may
be a particularly important parameter in the chemotactic responses of leukocytes, and demonstrate the
potential for RGS family members to regulate cellular adhesive and migratory behaviors (Bowman, 1998).
The newly recognized regulators of G protein signaling (RGS) attenuate heterotrimeric G protein signaling
pathways. An IL-2-induced gene was cloned from human T cells, cytokine-responsive gene 1, which
encodes a member of the RGS family, RGS16. The RGS16 protein binds Gialpha and Gqalpha proteins
present in T cells, and inhibits Gi- and Gq-mediated signaling pathways. By comparison, the
mitogen-induced RGS2 inhibits Gq but not Gi signaling. Moreover, the two RGS genes exhibit marked
differences in expression patterns. The IL-2-induced expression of the RGS16 gene in T cells is
suppressed by elevated cAMP, whereas the RGS2 gene shows a reciprocal pattern of regulation by these
stimuli. Because the mitogen and cytokine receptors that trigger expression of RGS2 and RGS16 in T
cells do not activate heterotrimeric G proteins, these RGS proteins and the G proteins that they regulate
may play a heretofore unrecognized role in T cell functional responses to Ag and cytokine activation (Beadling, 1999).
Regulator of G-protein signaling (RGS) proteins increase the intrinsic guanosine triphosphatase (GTPase)
activity of G-protein alpha subunits in vitro, but how specific G-protein-coupled receptor systems are
targeted for down-regulation by RGS proteins remains uncharacterized. The GTPase
specificity of RGS12 is described and four alternatively spliced forms of human RGS12 mRNA are identified. Two RGS12
isoforms of 6.3 and 5.7 kilobases (kb), encoding both an N-terminal PDZ (PSD-95/Dlg/ZO-1) domain
and the RGS domain, are expressed in most tissues, with highest levels observed in testis, ovary, spleen,
cerebellum, and caudate nucleus. The 5.7-kb isoform has an alternative 3' end encoding a putative
C-terminal PDZ domain docking site. Two smaller isoforms (3.1 and 3.7 kb), which lack the PDZ
domain and encode the RGS domain with and without the alternative 3' end, respectively, are most
abundantly expressed in brain, kidney, thymus, and prostate. In vitro biochemical assays indicate that
RGS12 is a GTPase-activating protein for Gi class alpha subunits. Biochemical and interaction trap
experiments suggest that the RGS12 N terminus acts as a classical PDZ domain, binding selectively to
C-terminal (A/S)-T-X-(L/V) motifs as found within both the interleukin-8 receptor B (CXCR2) and the
alternative 3' exon form of RGS12. The presence of an alternatively spliced PDZ domain within RGS12
suggests a mechanism by which RGS proteins may target specific G-protein-coupled receptor systems
for desensitization (Snow, 1998a).
Subcellular localization directed by specific A kinase anchoring proteins (AKAPs) is a mechanism for
compartmentalization of cAMP-dependent protein kinase (PKA). Using a two-hybrid screen, a novel
AKAP was isolated. Because it interacts with both the type I and type II regulatory subunits, it was
defined as a dual specific AKAP or D-AKAP1. The cloning and characterization of another
novel cDNA isolated from that screen is reported. This new member of the D-AKAP family, D-AKAP2, also binds
both types of regulatory subunits. A message of 5 kb pairs was detected for D-AKAP2 in all embryonic
stages and in all adult tissues tested. In brain, skeletal muscle, kidney, and testis, a 10-kb mRNA was
identified. In testis, several small mRNAs were observed. Therefore, D-AKAP2 represents a novel family
of proteins. cDNA cloning from a mouse testis library has identified the full length D-AKAP2. It is composed
of 372 amino acids, which includes the R binding fragment, residues 333-372, at its C-terminus. Based on
coprecipitation assays, the R binding domain interacts with the N-terminal dimerization domain of RIalpha
and RIIalpha. A putative RGS domain was identified near the N-terminal region of D-AKAP2. The
presence of this domain raises the intriguing possibility that D-AKAP2 may interact with a Galpha protein,
thus providing a link between the signaling machinery at the plasma membrane and the downstream
kinase (L. Huang, 1997).
Identification of a new family of proteins (RGS proteins) that function as negative regulators of G protein
signaling has sparked new understanding of desensitization of this signaling process. Recent studies with
several mammalian RGS proteins has delineated their ability to interact with and function as
GTPase-activating proteins specifically for G proteins in the Gi family. The
functional activity of RGS3 and a truncated form of RGS3 were investaged on G protein-coupled receptor-mediated
activation of adenylyl cyclase, phosphoinositide phospholipase C, and mitogen-activated protein kinase in
intact cells. Polymerase chain reaction and 5'-rapid amplification of cDNA ends analyses reveals the
tissue-specific expression of a short form of the RGS3 transcript that encodes the approximate
carboxyl-terminal half of RGS3. This truncated form of RGS3 (RGS3T) has been shown to function
as a negative regulator of pheromone signaling in yeast. Baby hamster kidney cells transiently transfected with RGS3T
cDNA exhibit a pronounced impairment in platelet-activating factor receptor-stimulated inositol
phosphate production, a pertussis toxin-insensitive response. Similarly, calcitonin gene-related peptide
receptor-stimulated increases in intracellular cAMP and pituitary adenylate-cyclase activating polypeptide
receptor-stimulated increases in both cAMP and inositol phosphates are reduced significantly in RGS3T
transfectants compared with vector-transfected control cells. In contrast, baby hamster kidney cells
transfected with the full-length RGS3 cDNA show no impairment in cAMP and inositol phosphate
production mediated by these G protein-coupled receptors. However, lysophosphatidic acid
receptor-stimulated phosphorylation of endogenous ERK1 and ERK2 is impaired markedly in both
RGS3 and RGS3T transfectants, demonstrating the functional ability of both RGS forms to modulate
Gi-mediated signaling. These results provide the first evidence for regulatory effects of an RGS protein
on Gs- and Gq-mediated signaling in intact cells and document that the carboxyl-terminal region of RGS3
comprises the structural domain for this activity (Chatterjee, 1997).
Heterotrimeric G proteins transduce multiple growth-factor-receptor-initiated and intracellular signals that
may lead to activation of the mitogen-activated or stress-activated protein kinases. A novel p53 target gene (A28-RGS14) is reported that is induced in response to genotoxic stress
and encodes a novel member of a family of regulators of G protein signaling (RGS) proteins with
proposed GTPase-activating protein activity. Overexpression of A28-RGS14p protein inhibits both Gi-
and Gq-coupled growth-factor-receptor-mediated activation of the mitogen-activated protein kinase
signaling pathway in mammalian cells. Thus, through the induction of A28-RGS14, p53 may regulate
cellular sensitivity to growth and/or survival factors acting through G protein-coupled receptor pathways (Buckbinder, 1997).
RGS14 possesses an N-terminal RGS domain, two Raf-like Ras-binding domains, and a GoLoco motif, which has GDP dissociation inhibitor activity. This study shows that unique among the known mammalian RGS proteins, RGS14 localizes in centrosomes. Its first Ras-binding domain is sufficient to target RGS14 to centrosomes. RGS14 also shuttles between the cytoplasm and nucleus, and its nuclear export depends on the CRM-1 nuclear export receptor. Mutation of a nuclear export signal or treatment with leptomycin B causes nuclear accumulation of RGS14 and its association with promyelocytic leukemia protein nuclear bodies. Furthermore, a point mutant defective in nuclear export fails to target to centrosomes, suggesting that nuclear cytoplasmic shuttling is necessary for its proper localization. Mild heat stress, but not proteotoxic or transcription-linked stresses, re-localizes the RGS14 from the cytoplasm to promyelocytic leukemia nuclear bodies. Expression of RGS14, but not point mutants that disrupt the functional activity of its RGS domain or GoLoco motif, enhances the reporter gene activity. The multifunctional domains and the dynamic subcellular localization of RGS14 implicate it in a diverse set of cellular processes including centrosome and nuclear functions and stress-induced signaling pathways.
Chronic cocaine administration reduces G protein signaling efficacy. The expression of AGS3, which binds to GialphaGDP and inhibits GDP dissociation, is upregulated in the prefrontal cortex (PFC) during late withdrawal from repeated cocaine administration. Increased AGS3 is mimicked in the PFC of drug-naive rats by microinjecting a peptide containing the Giα binding domain (GPR) of AGS3 fused to the cell permeability domain of HIV-Tat. Infusion of Tat-GPR mimicked the phenotype of chronic cocaine-treated rats by manifesting sensitized locomotor behavior and drug seeking and by increasing glutamate transmission in nucleus accumbens. By preventing cocaine withdrawal-induced AGS3 expression with antisense oligonucleotides, signaling through Giα was normalized, and both cocaine-induced relapse to drug seeking and locomotor sensitization were prevented. When antisense oligonucleotide infusion was discontinued, drug seeking and sensitization were restored. It is proposed that AGS3 gates the expression of cocaine-induced plasticity by regulating G protein signaling in the PFC (Bowers, 2004).
Home page: The Interactive Fly © 1995, 1996 Thomas B. Brody, Ph.D.
The Interactive Fly resides on the
loco:
Biological Overview
| Regulation
| Developmental Biology
| Effects of Mutation
| References
Society for Developmental Biology's Web server.